Fazekas, Andreas S.
Aboulghaith, Mei
Kriz, Ruxandra C.
Urban, Matthias
Breyer, Marie-Kathrin
Breyer-Kohansal, Robab
Burghuber, Otto-Chris
Hartl, Sylvia
Funk, Georg-Christian
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 27 January 2017
Accepted: 4 July 2018
First Online: 31 July 2018
Compliance with ethical guidelines
:
: A.S. Fazekas, M. Aboulghaith, R.C. Kriz, M. Urban, M.-K. Breyer, R. Breyer-Kohansal, O.-C. Burghuber, and S. Hartl declare that they have no competing interests. G.-C. Funk reports personal fees from Glaxo-Smith Kline, Boehringer Ingelheim, Astra Zeneca and Menarini during the conduct of the study.
: The study was conducted according to the principles of the Declaration of Helsinki. The ethics committee of the city of Vienna granted an exemption from requiring ethics approval (reference number EK 09-197_NZ). Given the retrospective, observational design of the trial, the need for informed consent was waived.